Wiadomości INC SA - strona: 13

Sprinklr Inc (CXM) Beats Q4 FY26 EPS Estimates

Sprinklr Inc (CXM) delivered Q4 2025 adjusted earnings of $0.10 per share, surpassing analysts' $0.09 forecast (beat by 10.0%). Top-line revenue was $219.1... The post Sprinklr Inc (CXM) Beats Q4 FY26 EPS Estimates first appeared on Alphastreet.

ATRenew Inc (RERE) Reports Q4 Earnings

**ATRenew Inc Reports Q4 2025 Results** The post ATRenew Inc (RERE) Reports Q4 Earnings first appeared on Alphastreet.

Cadre Holdings, Inc. (CDRE) Misses Q4 EPS Estimates

**Cadre Holdings Reports Q4 2025 Earnings Miss** The post Cadre Holdings, Inc. (CDRE) Misses Q4 EPS Estimates first appeared on Alphastreet.

Groupon Inc. (GRPN) Misses Q4 EPS Estimates

Groupon Inc (GRPN) posted Q4 2025 gaap EPS of $0.17, falling short of the $0.50 estimate (miss by 66.0%). Top-line revenue was $136.0M. The results mark a ... The post Groupon Inc. (GRPN) Misses Q4 EPS Estimates first appeared on Alphastreet.

Serve Robotics Inc (SERV) Reports Wider Q4 Loss Than Expected

Serve Robotics Inc (SERV) posted a Q4 2025 adjusted loss of $0.49 per share, wider than the -$0.44 expected loss (12.2% wider). The company generated $161.... The post Serve Robotics Inc (SERV) Reports Wider Q4 Loss Than Expected first appeared on Alphastreet.

Rapport Therapeutics Inc (RAPP) Reports a Wider Loss for Q4 2025

Rapport Therapeutics Inc (RAPP) posted a Q4 2025 gaap loss of $0.72 per share, wider than the -$0.67 expected loss (6.8% wider). The clinical-stage biophar... The post Rapport Therapeutics Inc (RAPP) Reports a Wider Loss for Q4 2025 first appeared on Alphastreet.

Verrica Pharmaceuticals inc (VRCA) Reports Q4 Earnings

**Verrica Pharmaceuticals Reports Q4 2025 Results** The post Verrica Pharmaceuticals inc (VRCA) Reports Q4 Earnings first appeared on Alphastreet.

Arq Inc (ARQ) Narrows Loss Q4 EPS Estimates by 111.1%

**Arq Inc Reports Q4 2025 Earnings** The post Arq Inc (ARQ) Narrows Loss Q4 EPS Estimates by 111.1% first appeared on Alphastreet.

Custom Truck One Source Inc (CTOS) Beats Q4 EPS Estimates

Custom Truck One Source Inc (NYSE:CTOS) reported fourth quarter results that exceeded Wall Street expectations. Q4 2025 gaap earnings at Custom Truck One S... The post Custom Truck One Source Inc (CTOS) Beats Q4 EPS Estimates first appeared on Alphastreet.

Priority Technology Holdings, Inc (PRTH) Reports Q4 Results

Priority Technology Holdings, Inc (PRTH) delivered Q4 2025 adjusted earnings of $0.27 per share, below analysts' $0.28 forecast (miss by 3.6%). Top-line re... The post Priority Technology Holdings, Inc (PRTH) Reports Q4 Results first appeared on Alphastreet.

Nuwellis Inc (NUWE) Reports Q4 Earnings

**Nuwellis Inc Reports Q4 2025 Results** The post Nuwellis Inc (NUWE) Reports Q4 Earnings first appeared on Alphastreet.

FreightCar America Inc (RAIL) Misses Q4 EPS Estimates

FreightCar America Inc (RAIL) delivered Q4 2025 adjusted earnings of -$0.17 per share, below analysts' $0.19 forecast (miss by 191.1%). Revenue totaled $55... The post FreightCar America Inc (RAIL) Misses Q4 EPS Estimates first appeared on Alphastreet.

Voyager Technologies Inc (VOYG) Reports Wider Q4 Loss Than Expected

**Voyager Technologies Inc Reports Q4 2025 Earnings** The post Voyager Technologies Inc (VOYG) Reports Wider Q4 Loss Than Expected first appeared on Alphastreet.

Tenax Therapeutics Inc (TENX) Q4 Loss Widens, But Beats Estimates

**Tenax Therapeutics Narrows Q4 Loss, Beats Expectations** The post Tenax Therapeutics Inc (TENX) Q4 Loss Widens, But Beats Estimates first appeared on Alphastreet.

PZ CORMAY S.A. - Zakończenie przeglądu opcji strategicznych dla projektu PZ CORMAY S.A. Equisse 400i - zawarcie umowy pomiędzy PZ CORMAY S.A. a Planet Innovation Products Inc. z centralą w USA

KVH Industries Inc (KVHI) Reports Q4 Earnings

KVH Industries Inc (KVHI) reported Q4 2025 gaap earnings of $0.02 per share. No consensus estimate was available for comparison. Revenue totaled $30.5M for... The post KVH Industries Inc (KVHI) Reports Q4 Earnings first appeared on Alphastreet.

Nio Inc (NIO) Beats Q4 EPS Estimates by a Wide Margin

Nio Inc (NIO) delivered Q4 2025 gaap earnings of $0.29 per share, surpassing analysts' $0.05 forecast (beat by 441.4%). Top-line revenue was $4.61B. The Ch... The post Nio Inc (NIO) Beats Q4 EPS Estimates by a Wide Margin first appeared on Alphastreet.

Esperion Therapeutics, Inc (ESPR) Misses Q4 EPS Estimates

**BREAKING: Esperion Therapeutics Reports Q4 2025 Earnings Miss** The post Esperion Therapeutics, Inc (ESPR) Misses Q4 EPS Estimates first appeared on Alphastreet.

Protara Therapeutics, Inc. (TARA) Reports Narrower Loss for Q4

Protara Therapeutics, Inc. (TARA) posted a Q4 2025 gaap loss of $0.37 per share, wider than the -$0.31 expected loss (18.6% wider). The clinical-stage biop... The post Protara Therapeutics, Inc. (TARA) Reports Narrower Loss for Q4 first appeared on Alphastreet.

Inspired Entertainment, Inc (INSE) Misses Q4 EPS Estimates

Inspired Entertainment, Inc (INSE) reported Q4 2025 gaap earnings of -$0.18 per share, missing the $0.21 consensus estimate (miss by 186.9%). The company g... The post Inspired Entertainment, Inc (INSE) Misses Q4 EPS Estimates first appeared on Alphastreet.

ISIN:	PLINCLT00015
Data debiutu:	09.08.2006
Liczba akcji:	15 043 099
Kapitalizacja:	28 882 750
Enterprise Value:	28 772 750
Branża:	Działalność inwestycyjna

Nazwa:	INC SPÓŁKA AKCYJNA
Adres:	ul. Abpa Antoniego Baraniaka 6, 61-131, Poznań, Polska
CEO:	Paweł Śliwiński
NIP:	7781024498
REGON:	630316445
KRS:	0000028098
Telefon:	+48 (61) 851 86 77
WWW:	http://www.incsa.pl/

Wiadomości INC

INC SPÓŁKA AKCYJNA

Informacje